Unlocking the Sleepwalking Brain: New Insights into Nighttime Wandering
"Groundbreaking research reveals how altered brain activity during sleep and wakefulness may trigger sleepwalking episodes, offering clues for better management and potential treatments."
Sleepwalking, also known as somnambulism, is a fascinating and sometimes alarming phenomenon characterized by performing complex activities while still asleep. Affecting up to 4% of adults, it's more than just a quirky behavior; it can involve risks of injury and has long puzzled sleep researchers.
Traditionally, sleepwalking has been viewed as a disorder of arousal, where the brain struggles to transition fully from sleep to wakefulness. However, recent research is shifting this perspective, highlighting the importance of slow-wave sleep (SWS)—the deepest stage of non-rapid eye movement (NREM) sleep—and the unique brain dynamics that occur during these episodes.
Now, a new study utilizing single photon emission computed tomography (SPECT) has shed light on the distinct brain perfusion patterns in sleepwalkers, both during wakefulness after sleep deprivation and during slow-wave sleep. This groundbreaking research offers fresh insights into the neurological underpinnings of sleepwalking and potential avenues for future interventions.
How Common Is Sleepwalking?
Sleepwalking, also known as somnambulism, is classified as a parasomnia—a disorder involving combined sleep and wakefulness. A systematic review and meta-analysis published in PLOS ONE found that sleepwalking is thought to be a common arousal disorder, though its epidemiology had not been thoroughly examined prior to that study. Community surveys suggest the behavior is far from rare: one U.S.-based poll found that 21 percent of respondents had witnessed someone sleepwalking, while 11.4 percent reported being prone to episodes themselves. Prevalence estimates vary across studies, but the condition appears to affect a meaningful share of the population.
Diagnosis and Management of Sleepwalking
Sleepwalking involves undesirable behaviors such as walking during abrupt but limited arousals from deep non-rapid eye movement (NREM) slow-wave sleep, and it typically occurs during the first third of the night. It is considered one of the leading causes of sleep-related injury and plays a growing role in medicolegal cases involving sleep-related violence. Accurate diagnosis is crucial for proper management, yet several widely held views of sleepwalking are characterized by key misconceptions that can hinder care. The most effective management approach focuses on ensuring a safe sleeping environment and treating underlying sleep disorders, with pharmacotherapy reserved for cases where there is a risk of injury.
A Long-Standing Mystery
Sleepwalking has been documented for centuries and was recognized long before modern sleep science emerged. Early medical literature described somnambulism as a puzzling state in which individuals appeared to be awake while remaining functionally asleep. The formal classification of sleepwalking as a parasomnia developed alongside advances in polysomnography and sleep staging in the twentieth century. Despite this long history, fundamental questions about the mechanisms driving nighttime wandering remain an active area of investigation.
Decoding the Sleepwalking Brain: Key Findings
The study compared 10 sleepwalkers with 10 age- and sex-matched controls, examining their brain activity using SPECT scans after a period of sleep deprivation. This approach allowed researchers to observe how brain perfusion—the delivery of blood to brain tissues—differed between the two groups in both resting-state wakefulness and during SWS.
- Frontal Regions: Sleepwalkers exhibited decreased perfusion in bilateral frontal regions, including the superior frontal, middle frontal, and medial frontal gyri. These areas are crucial for higher-level cognitive functions like decision-making and impulse control.
- Parietal and Temporal Regions: During slow-wave sleep, reduced perfusion was also found in the left postcentral gyrus, insula, and superior temporal gyrus. These regions are involved in sensory processing, body awareness, and auditory processing.
- Increased Perfusion in the Right Parahippocampal Gyrus: Interestingly, during wakefulness, sleepwalkers showed increased perfusion in the right parahippocampal gyrus, an area associated with memory and spatial navigation.
What New Studies Reveal About Sleepwalking Triggers
A 2024 study published in Sleep Medicine examined the differential effects of sleep deprivation on sleepwalking events and found that 17 percent of patients experienced episodes exclusively during recovery sleep, while only 2 percent had episodes solely at baseline. Sleep deprivation had similar facilitating effects on somnambulistic events regardless of the patient's age of onset or whether they had a positive or negative family history. A 2025 review in the Journal of Sleep Research estimated that sleepwalking affects approximately 2 percent to 4 percent of the general adult population and carries considerable potential for harm. These findings suggest that sleep deprivation is a potent and consistent trigger across different patient profiles.
Challenging Misconceptions About Sleepwalking
Despite its portrayal in popular culture as a harmless or even entertaining curiosity, sleepwalking can pose significant risks and challenges for those who experience it. The Mayo Clinic notes that sleepwalking is more common in children than adults and that most children outgrow it by their teenage years, leading some to dismiss it as a benign phase. However, sleepwalking that occurs frequently may suggest an underlying sleep disorder or other medical condition that warrants evaluation. Occasional episodes may not require treatment, but persistent sleepwalking can result in injury and disruption to daily life.
Benign vs. Complex Sleepwalking
Sleepwalking is not usually serious, and preventive safety measures can keep it from causing injuries, according to Cleveland Clinic. However, not all sleepwalking is alike—some cases involve simple movements while others escalate into complex behaviors like leaving the house or driving. Distinguishing between benign sleepwalking and complex somnambulism is essential, as the latter may require professional intervention. Certain clinical triggers indicate when adult sleepwalking warrants deeper medical evaluation rather than simple reassurance.
Implications and Future Directions
This study opens exciting new avenues for understanding and potentially treating sleepwalking. By identifying specific brain regions involved in the disorder, researchers can now focus on developing targeted interventions to normalize brain activity and reduce the frequency and severity of episodes. Further research is needed to explore the long-term effects of these brain perfusion differences and to determine whether interventions like cognitive behavioral therapy or targeted brain stimulation can effectively address the underlying neurological imbalances in sleepwalkers. This research paves the way for a future where sleepwalking is better understood and managed, leading to safer and more restful nights for those affected.
Expert Perspectives on Treating Sleepwalking
Expert opinion published in Expert Opinion on Pharmacotherapy places sleepwalking prevalence at 2 to 14 percent in children and 1.6 to 2.4 percent in adults. The consensus holds that occasional benign episodes can be managed conservatively through sleep hygiene and environmental safety measures. However, recurrent sleepwalking that carries a risk of injury to the individual or others mandates immediate treatment, including pharmacotherapy when appropriate. This guidance underscores the importance of individualized assessment rather than a one-size-fits-all approach to care.
Advances in Sleep Medicine
The American Academy of Sleep Medicine highlighted key trends shaping the practice of sleep medicine in early 2026, noting recent developments in technology and public health that are influencing how sleep disorders are studied and treated. As diagnostic tools become more sophisticated, researchers are gaining new insights into the neurological underpinnings of parasomnias like sleepwalking. Advances in wearable sleep monitoring and neuroimaging may eventually enable more precise identification of individuals at risk. These developments point toward a future where sleepwalking management becomes increasingly personalized and evidence-driven.
The Clinical and Legal Stakes of Sleepwalking
Sleepwalking can give rise to a wide range of adverse consequences and stands as one of the leading causes of sleep-related injury. Accurate diagnosis is not only crucial for proper management but is imperative in an ever-increasing number of medicolegal cases implicating sleep-related violence. Unfortunately, several widely held views of sleepwalking are characterized by key misconceptions that can lead to misdiagnosis or inappropriate treatment. Addressing these systemic challenges requires greater clinical awareness and continued research into the pathophysiological mechanisms underlying the disorder.
When Psychology Meets the Sleeping Brain
Two published case reports demonstrate that psychological factors may trigger sleepwalking episodes, suggesting that the mind's unresolved conflicts can manifest during sleep. In both cases, psychotherapy helped patients develop strategies to address their individual psychological conflicts, relieving them of sleepwalking-related symptoms and reducing both frequency and intensity of episodes. Another case study documented an adult sleepwalker whose events recurred after years of remission, triggered by sleep deprivation. These cases highlight that effective treatment often requires looking beyond the sleeping brain to the person's emotional and psychological landscape.